Scrip Asks... What Does 2025 Hold For Biopharma? Part 4: Artificial Intelligence and Data Science
From Sci-Fi To Table Stakes
More than 50 executives across industry share their expectations for the impact of AI on the biopharma industry over the coming year. While target identification and drug discovery featured highly, the opportunities to engage with patients and healthcare providers more effectively and the need for suitable regulatory frameworks were also flagged up.
